High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications

Biochemical and Biophysical Research Communications

Volumn 432, Issue 2, 2013, Pages 339-344

  Yadranji Aghdam, Saeed ^a   Gurel, Zafer ^a   Ghaffarieh, Alireza ^a   Sorenson, Christine M ^a   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Hyperglycemia; PA28 proteasome regulator; Pericytes

Indexed keywords

PROTEASOME; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERICYTE; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RETINA CELL; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; CHOROID; CULLIN PROTEINS; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; GLUCOSE; HYPERGLYCEMIA; KIDNEY GLOMERULUS; MICE; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINA; UBIQUITINATION;

MUS;

EID: 84875262617     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.101     Document Type: Article

References (34)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
2. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv. Cardiol. 2008, 45:1-16.
3. Curtis T.M., Gardiner T.A., Stitt A.W. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?. Eye (London) 2009, 23:1496-1508.
4. Denis U., Lecomte M., Paget C., Ruggiero D., Wiernsperger N., Lagarde M. Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction. Free Radical Biol. Med. 2002, 33:236-247.
5. Liu B., Bhat M., Padival A.K., Smith D.G., Nagaraj R.H. Effect of dicarbonyl modification of fibronectin on retinal capillary pericytes. Invest. Ophthalmol. Vis. Sci. 2004, 45:1983-1995.
6. Frank R.N. Diabetic retinopathy. N. Engl. J. Med. 2004, 350:48-58.
7. Kanwar Y.S., Sun L., Xie P., Liu F.Y., Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu. Rev. Pathol. 2011, 6:395-423.
8. Zhong Y., Wang J.J., Zhang S.X. Intermittent but not constant high glucose induces ER stress and inflammation in human retinal pericytes. Adv. Exp. Med. Biol. 2012, 723:285-292.
9. Huang Q., Sheibani N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am. J. Physiol. Cell Physiol. 2008, 295:C1647-1657.
10. Metzger M.B., Hristova V.A., Weissman A.M. HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 2012, 125:531-537.
11. Dong X., Liu J., Zheng H., Glasford J.W., Huang W., Chen Q.H., Harden N.R., Li F., Gerdes A.M., Wang X. In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1417-1425.
12. Pickering A.M., Linder R.A., Zhang H., Forman H.J., Davies K.J. Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J. Biol. Chem. 2012, 287:10021-10031.
13. Murakami T., Frey T., Lin C., Antonetti D.A. Protein kinase cbeta phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo. Diabetes 2012, 61:1573-1583.
14. Liu H., Yu S., Xu W., Xu J. Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 2012.
15. Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S., Imai Y., Kim J., He H.H., Igarashi K., Kanno J., Ohtake F., Kitagawa H., Roeder R.G., Brown M., Kato S. GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 2011, 480:557-560.
16. Scheef E.A., Sorenson C.M., Sheibani N. Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1. Am. J. Physiol. Cell Physiol. 2009, 296:C724-734.
17. Su X., Sorenson C.M., Sheibani N. Isolation and characterization of murine retinal endothelial cells. Mol. Vis. 2003, 9:171-178.
18. Bech-Otschir D., Helfrich A., Enenkel C., Consiglieri G., Seeger M., Holzhutter H.G., Dahlmann B., Kloetzel P.M. Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome. Nat. Struct. Mol. Biol. 2009, 16:219-225.
19. Barber A.J., Antonetti D.A., Kern T.S., Reiter C.E.N., Soans R.S., Krady J.K., Levison S.W., Gardner T.W., Bronson S.K. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Vis. Sci. 2005, 46:2210-2218.
20. Knowlton J.R., Johnston S.C., Whitby F.G., Realini C., Zhang Z., Rechsteiner M., Hill C.P. Structure of the proteasome activator REGalpha (PA28alpha). Nature 1997, 390:639-643.
21. Cascio P., Goldberg A.L. Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. Methods Enzymol. 2005, 398:336-352.
22. Kinouchi R., Takeda M., Yang L., Wilhelmsson U., Lundkvist A., Pekny M., Chen D.F. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat. Neurosci. 2003, 6:863-868.
23. Hellstrom M., Ruitenberg M.J., Pollett M.A., Ehlert E.M., Twisk J., Verhaagen J., Harvey A.R. Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection. Gene Ther. 2009, 16:521-532.
24. Ibrahim A.S., El-Remessy A.B., Matragoon S., Zhang W., Patel Y., Khan S., Al-Gayyar M.M., El-Shishtawy M.M., Liou G.I. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 2011, 60:1122-1133.
25. Alpers C.E., Seifert R.A., Hudkins K.L., Johnson R.J., Bowen-Pope D.F. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int. 1993, 43:286-294.
26. Lindahl P., Hellstrom M., Kalen M., Karlsson L., Pekny M., Pekna M., Soriano P., Betsholtz C. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998, 125:3313-3322.
27. Emanuele M.J., Elia A.E., Xu Q., Thoma C.R., Izhar L., Leng Y., Guo A., Chen Y.N., Rush J., Hsu P.W., Yen H.C., Elledge S.J. Global identification of modular cullin-RING ligase substrates. Cell 2011, 147:459-474.
28. Petroski M.D., Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6:9-20.
29. Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W. Dynamic O-Glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J. Biol. Chem. 2001, 276:9838-9845.
30. Geraldes P., Hiraoka-Yamamoto J., Matsumoto M., Clermont A., Leitges M., Marette A., Aiello L.P., Kern T.S., King G.L. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 2009, 15:1298-1306.
31. Grune T., Merker K., Sandig G., Davies K.J. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem. Biophys. Res. Commun. 2003, 305:709-718.
32. Shrikhande G.V., Scali S.T., da Silva C.G., Damrauer S.M., Csizmadia E., Putheti P., Matthey M., Arjoon R., Patel R., Siracuse J.J., Maccariello E.R., Andersen N.D., Monahan T., Peterson C., Essayagh S., Studer P., Guedes R.P., Kocher O., Usheva A., Veves A., Kaczmarek E., Ferran C. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS ONE 2010, 5:e14240.
33. Caramori M.L., Fioretto P., Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 2003, 52:1036-1040.
34. Luo Z.F., Qi W., Feng B., Mu J., Zeng W., Guo Y.H., Pang Q., Ye Z.L., Liu L., Yuan F.H. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome. Life Sci. 2011, 88:512-520.